Join BII on March 26, for a unique opportunity to meet CEO Emily Leproust from San Francisco-based Twist Bioscience, when she visits BioInnovation Institute’s Talk at the Square event series.
At the event, Emily Leproust will present the future outlook of biosciences and how Twist Bioscience accelerates applications that benefit from DNA writing, from health and medical breakthroughs to environmental sustainability, to improve the lives of people around the world.
As of 2017, Twist Biosciences raised 190 million dollars and IPO’ed in October 2018 to raise an additional 70 million dollars in its stock market debut.
Dr. Emily Leproust is an early pioneer in the high-throughput synthesis and sequencing of DNA and are working on disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data storage, agricultural biology, and industrial chemicals.
Dr. Leproust has published over 30 peer-reviewed papers—many on applications of synthetic DNA, and is the author of numerous patents. Emily Leproust was named 2015 Global Thinker by Foreign Policy Magazine.
Program of the day:
09:30-10.00 Doors open
10:00-10.45 Dr. Emily Leproust: ‘Powering the synthetic biology revolution’
10.45-11.00 Q&A session
11:00-11.45 Informal networking and closing reception
Please note, that the event has free admittance with 100 tickets available. Please sign up quickly to secure
your seat.
About TWIST Bioscience
Twist Bioscience, work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, TWIST customers are developing ways to better lives and improve the sustainability of the planet.
Twist Bioscience has created a revolutionary silicon-based DNA synthesis platform, that offers precision at a scale otherwise unavailable.
- Innovative silicon-based DNA Synthesis Platform enables the production of high-quality synthetic DNA faster and more affordable than ever before.
- Platform technology overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis.
- Quality and quantity of our synthetic biology tools help researchers rapidly realize opportunities ahead.
Read more on https://www.twistbioscience.com/
About Emily Leproust
As an early pioneer in the high-throughput synthesis and sequencing of DNA, Dr. Leproust is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data storage, agricultural biology, and industrial chemicals. In 2015, she was named one of Foreign Policy’s 100 Leading Global Thinkers for fast-tracking the building blocks of life, and Fast Company named her one of the most creative people in business for synthesizing DNA faster than ever. Prior to Twist Bioscience, she held escalating positions at Agilent Technologies where she architected the successful SureSelect product line that lowered the cost of sequencing and elucidated mechanisms responsible for dozens of Mendelian diseases. She also developed the Oligo Library Synthesis technology, where she initiated and led product and business development activities for the team. Dr. Leproust designed and developed multiple commercial synthesis platforms to streamline microarray manufacturing and fabrication. Prior to Agilent, she worked with Dr. X. Gao at the University of Houston developing DNA and RNA parallel synthesis processes on solid support, a project developed commercially by Xeotron Corporation. Dr. Leproust has published over 30 peer-reviewed papers—many on applications of synthetic DNA and is the author of numerous patents. She earned her Ph.D. in organic chemistry from the University of Houston and her M.Sc. in industrial chemistry from the Lyon School of Industrial Chemistry in France. Read more on https://www.twistbioscience.com/company/team and in this video about Writing DNA https://www.youtube.com/watch?v=YXkK-QuBU7s
About the Talks on the Square event series at BioInnovation Institute
The ‘Talks at the Square’ is an event series by BioInnovation Institute (BII) with a key focus on spreading ideas and knowledge in life science entrepreneurship to inspire researchers to bring science out of the lab and into the economy. The events feature high-level international speakers with topics that emphasize innovations and inspirational topics within biotech, medtech and pharma. The Talks at the Square events are hosted by BioInnovation Institute at the Square event space of the new BII facilities in Copenhagen Bio Science Park (COBIS) in Copenhagen. Read more about upcoming and past events here
https://bii.dk/upcoming-and-past-events/